HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

obsilazin

combination of above cpds; used in therapy of hypertension

Also Known As:

obsilazine

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Related Diseases

1.	Hypertension (High Blood Pressure) 01/01/1986 - "Obsilazin was established to have a good to moderate hypotensive effect in 75% of the treated 36 patients with moderate and severe hypertension under the condition of a 6-month open clinical experiment, not changing the heart rate. " 01/01/1986 - "[Treatment of hypertension with obsilazin]." 12/01/1983 - "[Long-term treatment of arterial hypertension with a new combined preparation obsilazin]." 12/01/1983 - "Thirty-three patients with essential hypertension and two with symptomatic arterial hypertension (Stage I-III) were treated for about two years with the drug obsilazin containing 50 mg propranolol and 50 mg dihydralazin per tablet (the maximum average dose of each drug was 174 mg/day). "
2.	Essential Hypertension 12/01/1983 - "Thirty-three patients with essential hypertension and two with symptomatic arterial hypertension (Stage I-III) were treated for about two years with the drug obsilazin containing 50 mg propranolol and 50 mg dihydralazin per tablet (the maximum average dose of each drug was 174 mg/day). "

Related Drugs and Biologics

1.	Tablets
2.	Propranolol (Inderal)